Skip to content

Clinical trials

Phase 1 Hypogonadism trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypogonadism Phase: Phase 1 Country / region: United States Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20062
20071
20082
20092
20102
20112
20133
20144
20162
20191
20211
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Terminated4
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital6
Repros Therapeutics Inc.3
Solvay Pharmaceuticals2
Stephanie B. Seminara, MD2
The University of Texas Medical Branch, Galveston2
University of Washington2
Acerus Pharmaceuticals Corporation1
Antares Pharma Inc.1
EMD Serono Research & Development Institute, Inc.1
Emory University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypogonadism29
Kallmann Syndrome4
Anemia, Sickle Cell1
Erectile Dysfunction1
Eunuchism1
Frailty1
Gonadal Dysgenesis1
Hyperprolactinemia1
Infertility, Male1
Multiple Endocrine Neoplasia Type 11

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.